AFSTYLA and IDELVION: Challenging the Paradigm in Hemophilia

7:15–7:45 pm
Thursday,September 13 Corporate Showcase Presentations

This program offers you the opportunity to:

  • Discuss current challenges in hemophilia A and B treatment 
  • Explore the features and benefits of both AFSTYLA and IDELVION
  • Discover valuable resources, tools, and support
  • Examine a case-based approach to hemophilia A and B
  • Share experiences, ask questions, and gain valuable information which will enable you to better treat patients with hemophilia A and B

CSL Berring

More in this category: « Key Considerations for the Only FDA-Approved oral TPO Receptor Agonist for the Treatment of Chronic ITP in Patients 1 year and Older Diagnosing aHUS: A Pediatric Patient Case Journey »
Venue:
Exhibit Hall Theater
Speaker:
Claudio Sandoval, MD